Male contraception: what is on the horizon?

Contraception

Volumn 78, Issue 4 SUPPL., 2008, Pages

  Blithe, Diana ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Hormonal approach; Male contraception; Sperm specific nonhormonal targets; Spermatogenesis

Indexed keywords

11BETA METHYL 19 NORTESTOSTERONE; 2 ETHYL 2,3,4,4A,5,9B HEXAHYDRO 8 IODO 7 METHYL 5 [4 CARBOMETHOXYPHENYL] 1H INDENO[1,2 C]PYRIDINE; ACYLINE; ADJUDIN; ANDROGEN; CONTRACEPTIVE AGENT; DIMETHANDROLONE; DIMETHANDROLONE UNDECANOATE; FOLLITROPIN; GAMENDAZOLE; GESTAGEN; GONADORELIN ANTAGONIST; GONADOTROPIN; LONIDAMINE; LUTEINIZING HORMONE; METHYLTESTOSTERONE; PYRIDINE DERIVATIVE; RTI 4587073; SELECTIVE ANDROGEN RECEPTOR MODULATOR; TESTOSTERONE; TESTOSTERONE UNDECANOATE; TRESTOLONE; UNCLASSIFIED DRUG;

ANDROGEN THERAPY; ARTICLE; BINDING AFFINITY; CONTRACEPTION; DRUG EFFICACY; DRUG MECHANISM; HORMONAL CONTRACEPTION; HORMONE SUBSTITUTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LIBIDO; LIVER TOXICITY; MALE FERTILITY; PROSTATE CANCER; SEXUAL FUNCTION; SINGLE DRUG DOSE; SPERMATOGENESIS; SPERMATOZOON MOTILITY; UNSPECIFIED SIDE EFFECT; VASECTOMY;

ANIMALS; CONTRACEPTION; CONTRACEPTIVE AGENTS, MALE; FORECASTING; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; SPERMATOGENESIS-BLOCKING AGENTS;

EID: 51449098819     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.03.018     Document Type: Article

References (35)

1. WHO, UNICEF, UNFPA, and The World Bank. Maternal mortality in 2005 (2007), World Health Organization, Geneva, Switzerland
2. Trussell J., and Wynn L.L. Reducing unintended pregnancy in the United States. Contraception 77 (2008) 1-5
3. Heinemann K., Saad F., Wiesemes M., White S., and Heinemann L. Attitudes toward male fertility control: results of a multinational survey on four continents. Hum Reprod 20 (2005) 549-556
4. In: Nass S.J., and Strauss III J.F. (Eds). New frontiers in contraceptive research: a blueprint for action (2004), The National Academies Press, Washington, DC
5. Handelsman D.J. Update in andrology. J Clin Endocrinol Metab 92 (2007) 4505-4511
6. Wu F.C. Hormonal approaches to male contraception: approaching reality. Mol Cell Endocrinol 250 (2006) 2-7
7. Wenk M., and Nieschlag E. Male contraception: a realistic option?. Eur J Contracept Reprod Health Care 11 (2006) 69-80
8. Matthiesson K.L., and McLachlan R.I. Male hormonal contraception: concept proven, product in sight?. Hum Reprod Update 12 (2006) 463-482
9. Coviello A.D., Bremner W.J., Matsumoto A.M., et al. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen. J Androl 25 (2004) 931-938
10. Herbst K.L., Coviello A.D., Page S., Amory J.K., Anawalt B.D., and Bremner W.J. A single dose of the potent gonadotropin-releasing hormone antagonist acyline suppresses gonadotropins and testosterone for 2 weeks in healthy young men. J Clin Endocrinol Metab 89 (2004) 5959-5965
11. Meriggiola M.C., Costantino A., Saad F., et al. Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate. J Clin Endocrinol Metab 90 (2005) 2005-2014
12. Gao W., and Dalton J.T. Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). Drug Discov Today 12 (2007) 241-248
13. Attardi B.J., Hild S.A., and Reel J.R. Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity. Endocrinology 147 (2006) 3016-3026
14. Anderson R.A., Wallace A.M., Sattar N., Kumar N., and Sundaram K. Evidence for tissue selectivity of the synthetic androgen 7-alpha-methyl-19-nortestosterone in hypogonadal men. J Clin Endocrinol Metab 88 (2003) 2784-2793
15. Wolgemuth D.J., Lele K.M., Jobanputra V., and Salazar G. The A-type cyclins and the meiotic cell cycle in mammalian male germ cells. Int J Androl 27 (2004) 192-199
16. Wolgemuth D.J., and Chung S.S. Retinoid signaling during spermatogenesis as revealed by genetic and metabolic manipulations of retinoic acid receptor alpha. Soc Reprod Fertil Suppl 63 (2007) 11-23
17. Hild S.A., Marshall G.R., Attardi B.J., et al. Development of l-CDB-4022 as a nonsteroidal male oral contraceptive: induction and recovery from severe oligospermia in the adult male cynomolgus monkey (Macaca fascicularis). Endocrinology 148 (2007) 1784-1796
18. Mruk D.D., Wong C.H., Silvestrini B., and Cheng C.Y. A male contraceptive targeting germ cell adhesion. Nat Med 12 (2006) 1323-1328
19. Tash J.S., Attardi B., Hild S.A., Chakrasali R., Jakkaraj S.R., and Georg G.I. A novel potent indazole carboxylic acid derivative blocks spermatogenesis and is contraceptive in rats after a single oral dose. Biol Reprod 78 (2008) 1127-1138
20. Wong C.H., Mruk D.D., Lee W.M., and Cheng C.Y. Targeted and reversible disruption of the blood-testis barrier by an FSH mutant-occludin peptide conjugate. FASEB J 21 (2007) 438-448
21. Qi H., Moran M.M., and Navarro B. All four CatSper ion channel proteins are required for male fertility and sperm cell hyperactivated motility. Proc Natl Acad Sci U S A 104 (2007) 1219-1223
22. Navarro B., Kirichok Y., and Clapham D.E. KSper, a pH-sensitive K+ current that controls sperm membrane potential. Proc Natl Acad Sci U S A 104 (2007) 7688-7692
23. Yeung C.H., Barfield J.P., and Cooper T.G. Physiological volume regulation by spermatozoa. Mol Cell Endocrinol 250 (2006) 98-105
24. Da Silva N., Silberstein C., Beaulieu V., et al. Postnatal expression of aquaporins in epithelial cells of the rat epididymis. Biol Reprod 74 (2006) 427-438
25. Sanchez G., Nguyen A.N., Timmerberg B., Tash J.S., and Blanco G. The Na,K-ATPase alpha4 isoform from humans has distinct enzymatic properties and is important for sperm motility. Mol Hum Reprod 12 (2006) 565-576
26. Thundathil J.C., Anzar M., and Buhr M.M. Na+/K+ATPase as a signaling molecule during bovine sperm capacitation. Biol Reprod 75 (2006) 308-317
27. Spehr M., Schwane K., Riffell J.A., Zimmer R.K., and Hatt H. Odorant receptors and olfactory-like signaling mechanisms in mammalian sperm. Mol Cell Endocrinol 250 (2006) 128-136
28. Nomura M., and Vacquier V.D. Proteins associated with soluble adenylyl cyclase in sea urchin sperm flagella. Cell Motil Cytoskeleton 63 (2006) 582-590
29. Quill T.A., Wang D., and Garbers D.L. Insights into sperm cell motility signaling through sNHE and the CatSpers. Mol Cell Endocrinol 250 (2006) 84-92
30. Strünker T., Weyand I., Bönigk W., et al. A K+-selective cGMP-gated ion channel controls chemosensation of sperm. Nat Cell Biol 8 (2006) 1149-1154
31. Darszon A., Treviño C.L., Wood C., et al. Ion channels in sperm motility and capacitation. Soc Reprod Fertil Suppl 65 (2007) 229-244
32. de Lamirande E., and O'Flaherty C. Sperm activation: role of reactive oxygen species and kinases. Biochim Biophys Acta 1784 (2008) 106-115
33. Krisfalusi M., Miki K., Magyar P.L., and O'Brien D.A. Multiple glycolytic enzymes are tightly bound to the fibrous sheath of mouse spermatozoa. Biol Reprod 75 (2006) 270-278
34. Miki K., Qu W., Goulding E.H., et al. Glyceraldehyde 3-phosphate dehydrogenase-S, a sperm-specific glycolytic enzyme, is required for sperm motility and male fertility. Proc Natl Acad Sci USA 101 (2004) 16501-16506
35. Page S.T., Amory J.K., Anawalt B.D., et al. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist. J Clin Endocrinol Metab 91 (2006) 4374-4380